Treatment Outcomes and Plasma Level of Ritonavir-boosted Lopinavir Monotherapy Among HIV-infected Patients Who Had Non-nucleoside Reverse Transcriptase Inhibitor (NRTI) and NNRTI Failure: A Pilot Study.
Phase of Trial: Phase III
Latest Information Update: 10 Nov 2011
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Lamivudine
- Indications HIV-1 infections
- Focus Therapeutic Use
- 10 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Nov 2009 New trial record.